课题基金 / 基金详情

Analysis of cellular signal transduction via Neurofibromatosis tumor suppressor gene products and development of their clinical targets

Analysis of cellular signal transduction via Neurofibromatosis tumor suppressor gene products and development of their clinical targets
通过神经纤维瘤病肿瘤抑制基因产物进行细胞信号转导的分析及其临床靶点的开发
批准号:
19390382
负责人:
ARAKI Norie
金额:
$11.9万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B)
财政年份:
2007
资助国家:
日本
项目状态:
已结题
起止时间:
2007 至 2009

项目摘要

项目成果

ARAKI Norie的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Neurofibromatosis (NF) tumor suppressor gene products, neurofibromin : NF1 and merlin : NF2, are though to be important regulators of cellular growth, differentiation, and apoptosis, and implicated in the neural abnormality of NF patients. However, the precise cellular function of NF proteins has yet to be clarified. In this study, we utilized proteomic strategies, functional annotation with a proprietary gene ontology (MANGO), and standard biochemical methods to identify proteins related to neuronal differentiation in PC12 cells, which serve as a representative model system for studying NF related neuronal biological processes. Of 1,600 non-redundant proteins quantitatively identified, 72 were novel nerve growth factor-responsive PC12 proteins mostly related to the biological processes of cell morphogenesis, apoptosis/survival, and cell differentiation. Using these proteomic strategies and database, we identified a set of NF-associating cellular proteins, including axon regulator CRMP-2. These associations were crucial for the axon formation in neuron and were regulated by a series of kinase activations by CDK5, GSK-3b, and Rho kinase being controlled by neurofibromin. Our study demonstrates that the functional association of NF proteins and their associating proteins are essential for neuronal cell differentiation and that lack of expression or abnormal regulation of NF proteins can result in impaired function of neural cells, which is likely a factor in NF-related pathogenesis.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
融合プロテオミクスによるがん研究の最前線とその応用
融合蛋白质组学癌症研究前沿及其应用
DOI: --
发表时间: 2009
期刊:
影响因子: --
作者: [HirotakaKanzaki, ほか, 荒木令江]
通讯作者: 荒木令江
生命のナゾ解きで病気を治す
解开生命之谜,治愈疾病
DOI: --
发表时间: 2009
期刊:
影响因子: --
作者: [三田雄一郎, ほか, 荒木令江]
通讯作者: 荒木令江
最新プロテオーム解析技術の健康科学への応用
最新蛋白质组分析技术在健康科学中的应用
DOI: --
发表时间: 2009
期刊:
影响因子: --
作者: [神崎浩孝, ほか, 荒木令江]
通讯作者: 荒木令江
抗体カクテルとnatural protein chipを用いた簡便な病態関連分子群解析法の開発
开发一种使用抗体混合物和天然蛋白质芯片分析疾病相关分子组的简单方法
DOI: --
发表时间: 2009
期刊:
影响因子: --
作者: [伊藤佐智夫, ほか, 荒木令江, 三田雄一郎, 荒木令江]
通讯作者: 荒木令江
50
    Analysis of molecular network on maintenance and differentiation of glioma stem cells
    • 批准号:
      25640068
    • 项目类别:
      Grant-in-Aid for Challenging Exploratory Research
    • 资助金额:
      $2.58万
    • 财政年份:
      2013
    • 负责人:
      ARAKI Norie
    • 依托单位:
    System development for microquantitative molecular analyses ofglioma stem cells
    • 批准号:
      23659693
    • 项目类别:
      Grant-in-Aid for Challenging Exploratory Research
    • 资助金额:
      $2.33万
    • 财政年份:
      2011
    • 负责人:
      ARAKI Norie
    • 依托单位:
    Study of the molecular mechanism of neural tumor formation mediatedby NF1 gene deficiency
    • 批准号:
      22390281
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $12.23万
    • 财政年份:
      2010
    • 负责人:
      ARAKI Norie
    • 依托单位:
    Study for the cellular signal transduction of Neurofibromatosis Type 1 and Type 2 tumor suppressor gene products to establish the medical molecular target for NF1 and NF2
    • 批准号:
      16390413
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $8.77万
    • 财政年份:
      2004
    • 负责人:
      ARAKI Norie
    • 依托单位:
    海外基金